Jones Day is advising a Fortune 500 life sciences company in its acquisition of a developer of medical devices for approximately $250 million in cash. In a separate transaction, Jones Day is advising the company in securing the right to acquire another developer of medical devices in a related field. Financial terms were not disclosed.